Pharmsure International Ltd

Name

Pharmsure International Ltd

Legal name

Pharmsure International Limited

Website

https://pharmsure.net

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Veterinary Vaccines

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAMAKAI

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)

Healthcare & Life Sciences/Veterinary & Animal Health/Animal Vaccines

SECONDARYHLAAAEAK

Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release)

Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics

SECONDARYAFAEANAK

Veterinary Pharmacy, Vaccine & Biologics Services

Agriculture & Food Production/Animal Production & Aquaculture/Animal Health & Veterinary Services

Keywords

• Poultry vaccines
• Veterinary pharmaceuticals
• Mycoplasma vaccines
• Animal health products
• Livestock medicines

Headquarters

HQ city

Metheringham

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations

Revenue model

1. Poultry Vaccine and Pharmaceutical Distribution: Pharmsure International distributes poultry vaccines, pharmaceuticals and other poultry healthcare products throughout Europe. They market products including MS-H Vaccine, Vaxsafe MG, and CalPid D+ through their distributor network.
2. Marketing Authorisation Services: As a European Marketing Authorisation Holder with EU ManA manufacturing licence, Pharmsure markets products under EU-wide Marketing Authorisations across multiple countries.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Pharmsure International Ltd is an independent poultry pharmaceutical company that develops, markets and distributes live temperature-sensitive mycoplasma vaccines (MS-H and Vaxsafe MG) and complementary poultry health products (CalPid D+) across Europe. The group holds EU-wide Marketing Authorisations and an EU ManA manufacturing licence, distributing through specialist poultry distributors and regional sales entities in the UK and Republic of Ireland.

Product overview

Pharmsure International Ltd is a specialist poultry pharmaceutical company offering a focused portfolio of poultry vaccines and medicines. The product range includes three core offerings: MS-H Vaccine (live Mycoplasma synoviae vaccine with EU Marketing Authorisation), Vaxsafe MG (live attenuated Mycoplasma gallisepticum vaccine based on ts-11 strain), and CalPid D+ (calcium and vitamin supplement for bone and egg shell quality). The company distributes through a network of poultry specialist distributors across Europe.

Differentiator

Problem solved

Functional benefit

Brands

• Vaxsafe: Brand name for Mycoplasma vaccines including Vaxsafe MG and Vaxsafe MS
• CalPid D+

Products and services

• MS-H Vaccine Third-generation live Mycoplasma synoviae vaccine administered as eyedrops suspension, providing long-lasting protection for laying hens, broiler breeders and layer breeders. The temperature-sensitive MS-H strain multiplies and persists in the upper trachea for the bird's entire life, providing continuous antigenic stimulation without surviving at the bird's core body temperature.
• Vaxsafe MG

Quantifiable outcome

• The vast majority of broiler breeders and a significant proportion of commercial layers in the European Union are vaccinated with MS-H Vaccine
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• BiopropertiescoreStrategic or Co-development Partner · 1 January 2024Bioproperties, based in Australia, develops and manufactures MS-H and TS-11 strain vaccines. Pharmsure has worked with Bioproperties since 2011 overseeing European market expansion of MS-H. The partnership has been extended with new products (MG304) and expanded territories including the Middle East and Africa. Pharmsure distributes MSH strain and TS11 strain vaccines under this partnership, with MG304 anticipated for European launch in 2027.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hipra: Spanish veterinary biopharmaceutical company specialising in animal vaccines, including poultry vaccines for major respiratory pathogens. Directly comparable as a specialist animal vaccine company competing in the same European poultry segment.
• Bioproperties: Australian developer and manufacturer of MS-H and TS-11 Mycoplasma vaccines. Bioproperties is Pharmsure's exclusive upstream manufacturing partner and works on the same vaccine technology, making it the closest comparable in product category.
• Vaxxinova: Animal vaccines company focused on livestock and poultry, including Mycoplasma vaccines. Directly comparable as a specialist poultry vaccine competitor with overlapping product categories.
• Huvepharma: Bulgarian-headquartered animal health company with a poultry vaccines and pharmaceuticals portfolio. Directly comparable as a niche European player offering vaccines and medicated feed additives to commercial poultry producers.

Broad incumbents

• Ceva Santé Animale: Global animal health company with broad poultry vaccine portfolio. Comparable as a large animal-health incumbent that overlaps in poultry vaccines and is also listed as a Pharmsure distributor in Spain and Portugal.
• MSD Animal Health: Animal health division of Merck with a global poultry vaccines and pharmaceuticals portfolio. Comparable as a broad incumbent active in the same European poultry vaccination market.
• Zoetis: Largest pure-play global animal health company with extensive poultry vaccine and pharmaceutical offerings. Comparable as a broad incumbent covering the same poultry health categories as Pharmsure.
• Phibro Animal Health: Diversified animal health and nutrition company with poultry vaccines and medicated feed additives. Comparable as a broad incumbent addressing similar poultry producer customers with overlapping product types.
• Elanco Animal Health: Global animal health company with poultry vaccines and pharmaceuticals. Comparable as a broad incumbent overlapping in poultry health products; also a Pharmsure distributor in Greece.
• Boehringer Ingelheim Animal Health: Global animal-health division with a major poultry vaccines franchise. Comparable as a broad incumbent in the same veterinary vaccine category and is also a Pharmsure distributor in Italy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmsure-international-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmsure International Ltd